Roche AG unit Genentech is placing a sizeable bet on the field of ubiquitin-specific protease (USP), "which is probably where kinases were 20 or 30 years ago," Tim Harrison, Almac Discovery Inc.'s vice president of discovery chemistry told BioWorld Today.